A 36-year-old man who was undergoing long-term hemodialysis was hospitalized with a two-day history of increasing dyspnea on exertion. He stated that he did not have cough, orthopnea, or night sweats.

LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with Novation for ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...

DENVER--(BUSINESS WIRE)--DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced ...